Chronic Kidney Disease: Reducing Risks of Progression -- Prismic ... PR Newswire UK (press release) SCOTTSDALE, Arizona, June 17, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based pharmaceutical company, today announced that it has secured exclusive licensing rights to Palmitoylethanolamide (PEA), including the ... |
